Search

Search results

1498 results found

HDAC11 suppresses the thermogenic program of adipose tissue via BRD2.

Publication: Journal Article

Bagchi, Rushita A, Bradley S Ferguson, Matthew S Stratton, Tianjing Hu, Maria A Cavasin, Lei Sun, Ying-Hsi Lin, et al. 2018. “HDAC11 Suppresses the Thermogenic Program of Adipose Tissue via BRD2.”. JCI Insight 3 (15).

Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Publication: Journal Article

Song, Kunhua, Young-Jae Nam, Xiang Luo, Xiaoxia Qi, Wei Tan, Guo N Huang, Asha Acharya, et al. 2012. “Heart Repair by Reprogramming Non-Myocytes With Cardiac Transcription Factors.”. Nature 485 (7400): 599-604.

Zhen Zhang

Person: Lab Manager

I have been the lab manager since 2021. I earned my master’s degree in Law from Shanghai University in China. I have over 15 years of experience in customer service and education. My primary focus is laboratory management and logistics. Additionally, I culture and differentiate human iPSCs and...

Amanda Sales Conniff

Person: Postdoctoral Fellow

As a postdoctoral researcher, I am immersed in cardiovascular research, utilizing advanced techniques to explore the intricate aspects of heart development and disease. Our lab uniquely combines human induced pluripotent stem cell-based platforms (hiPSC) with mouse models of cardiovascular disease...

Sean Christiansen

Person: Research Scientist

I am a research scientist under the tutelage of Dr. Song and I conduct translational research within the field of cardiology. I developed a research background in cancer immunology during my undergraduate career, which has lent itself well to understanding the signaling mechanisms for...

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study. 2022 Mar 14;

Publication: Journal Article

Comella, C, RA Hauser, SH Isaacson, D Truong, O Oguh, J Hui, ES Molho, et al. 2022. “Efficacy and Safety of Two IncobotulinumtoxinA Injection Intervals in Cervical Dystonia Patients With Inadequate Benefit from Standard Injection Intervals of Botulinum Toxin: Phase 4, Open-Label, Randomized, Noninferiority Study. 2022 Mar 14;”. Clin Park Relat Disord.

Trial of Prasinezumab in Early-Stage Parkinson's Disease. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. PMID: 35921451

Publication: Journal Article

Pagano, G, RA Hauser, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, RB Postuma, N Pavese, and . 2022. “Trial of Prasinezumab in Early-Stage Parkinson’s Disease. 2022 Aug 4;387(5):421-432. Doi: 10.1056/NEJMoa2202867. PMID: 35921451”. N Engl J Med.

IPX203 versus immediate-release carbidopa-levodopa for the treatment of motor fluctuations in Parkinson’s Disease: The RISE-PD Randomized Clinical Trial of Trial. 2023 Oct 1;80(10):1062-1069. doi: 10.1001/jamaneurol.2023.2679. PMID: 37578800

Publication: Journal Article

Hauser, RA, AJ Espay, AL Ellenbogen, HH Fernandez, SH Isaacson, PA LeWitt, WG Ondo, et al. 2023. “IPX203 versus Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson’s Disease: The RISE-PD Randomized Clinical Trial of Trial. 2023 Oct 1;80(10):1062-1069. Doi: 10.1001/Jamaneurol.2023.2679. PMID: 37578800”. JAMA Neurol.

The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.

Publication: Journal Article

Trosch, RM, CL Comella, RA Hauser, SN Caroff, WG Ondo, AC Shillington, BJ LaChappelle, CU Correll, and JH Friedman. 2024. “The Clinician’s Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.”. J Clin Psychiatry. 2024 Jan 24;85(1):23m14886. Doi: 10.4088/JCP.23m14886. PMID: 38270545.

Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results

Publication: Journal Article

Fernandez, HH, EA Macklin, RA Hauser, KL Chou, YO Cakmak, B Ozsoy, S Fahn, and Parkinson Study Group. 2024. “Intrinsic Auricular Muscle Zone Stimulation for Parkinson Disease: The EARSTIM-PD Phase II Multi-Center Pilot Study Results”. . Parkinsonism Relat Disord. 2024 Apr;121:105959. Doi: 10.1016/J.Parkreldis.2023.105959. Epub 2023 Dec 27. PMID: 38246833.